Tenaya Therapeutics, Inc. (TNYA)
 NASDAQ: TNYA · Real-Time Price · USD
 1.260
 -0.170 (-11.89%)
  At close: Oct 30, 2025, 4:00 PM EDT
1.280
 +0.020 (1.59%)
  After-hours: Oct 30, 2025, 7:58 PM EDT
Tenaya Therapeutics Employees
Tenaya Therapeutics had 97 employees as of December 31, 2024. The number of employees decreased by 43 or -30.71% compared to the previous year.
Employees 
 97
Change (1Y) 
 -43
Growth (1Y) 
 -30.71%
Revenue / Employee 
 n/a
Profits / Employee 
 -$1,026,979
Market Cap 
205.35M
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 97 | -43 | -30.71% | 
| Dec 31, 2023 | 140 | -1 | -0.71% | 
| Dec 31, 2022 | 141 | 35 | 33.02% | 
| Dec 31, 2021 | 106 | 31 | 41.33% | 
| Dec 31, 2020 | 75 | - | - | 
Related Stocks
| Company Name | Employees | 
|---|---|
| UnitedHealth Group | 400,000 | 
| Johnson & Johnson | 138,100 | 
| Thermo Fisher Scientific | 125,000 | 
| Abbott Laboratories | 114,000 | 
| AstraZeneca | 92,900 | 
| Novo Nordisk | 77,349 | 
| Novartis AG | 75,883 | 
| Merck & Co. | 75,000 | 
TNYA News
- 21 days ago - Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference - GlobeNewsWire
- 4 weeks ago - Tenaya Therapeutics to Participate in Upcoming October Investor Conferences - GlobeNewsWire
- 6 weeks ago - Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Tenaya Therapeutics, Inc. (TNYA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Tenaya Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Tenaya Therapeutics Presents Interim Data from MyClimb™ Natural History Study of MYBPC3-associated HCM Pediatric Patients at European Society of Cardiology Congress 2025 - GlobeNewsWire
- 2 months ago - Tenaya Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire
- 3 months ago - Tenaya Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire